Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2000
09/05/2000US6114537 Process for scavenging thiols
09/05/2000US6114536 Indolin-2-one derivatives
09/05/2000US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
09/05/2000US6114385 Administering l-carnitine, acyl l-carnitine derivatives or pharmacologically acceptable salts thereof for prophylaxis of diseases or treatment of cellular disorders caused by high levels of ceramide
09/05/2000US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine
09/05/2000US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
09/05/2000US6114356 Method for treating gastrointestinal disorders using (+) norcisapride
09/05/2000US6114338 Heterocyclic compounds
09/05/2000US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists
09/05/2000US6114322 Anticholesterol agent
09/05/2000US6114316 Combination of bisphosphonate and tetracycline
09/05/2000US6114304 Administering an amylin agonist such as pramlintide or pramlintide acetate; reducing gastric motility or delaying gastric emptying
09/05/2000US6113909 Pharmaceutical composition containing a mixed extract of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. for treatment of hepatitis C
09/05/2000US6113906 Water-soluble non-antigenic polymer linkable to biologically active material
09/02/2000CA2299893A1 Hiv therapy
08/2000
08/31/2000WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
08/31/2000WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease
08/31/2000WO2000050408A1 Pyridazin-3-one derivatives and medicines containing the same
08/31/2000WO2000050400A1 2-aminopyridines containing fused ring substituents
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000050056A1 Preparation for regulating lower bowel function
08/31/2000WO2000050048A2 Bone marrow transplantation for hepatic regeneration and repair
08/31/2000WO2000050046A1 Stabilized oral pharmaceutical composition containing iodide and iodate and method
08/31/2000WO2000050038A1 Pharmaceutical composition containing proton pump inhibitors
08/31/2000WO2000050027A1 Gabapentin derivative for preventing and treating visceral pain
08/31/2000WO2000027410A3 Composition and method for increasing weight gain and feed efficiency
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000DE10008042A1 Neurokinin-1-Rezeptorantagonisten Neurokinin-1 receptor antagonists
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/31/2000CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
08/31/2000CA2360528A1 Gabapentin derivative for preventing and treating visceral pain
08/30/2000EP1031350A1 Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030915A1 A novel gene and uses therefor
08/30/2000EP1030867A1 Mammalian milk growth factor
08/30/2000EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
08/30/2000EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS
08/30/2000EP1030654A1 Omeprazole formulation
08/30/2000EP0799198B1 Anti-inflammatory compounds
08/30/2000EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
08/30/2000EP0642348B1 Antibiotic cryptdin peptides and methods of their use
08/30/2000CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same
08/30/2000CN1265035A Method for inhibiting bone resorption
08/30/2000CN1265034A Treatment of hepatic cirrhosis
08/30/2000CN1264709A Human interleukin 11 derivative without amino acids at positions No.1-No.9 of N terminal
08/30/2000CN1264596A Polypeptide medicine as oral spray
08/30/2000CN1264595A Prescription for treating hepatism
08/30/2000CN1264587A Medicine for treating gastroenteropathy
08/30/2000CN1264586A Compound Chinese medicine for treating hepatocholepathy
08/30/2000CN1055924C Novel aminoalkyl benzoxazolinones and benzothizolinones and pharmaceutical compsns. and method for preparing same
08/30/2000CN1055861C Umbilicus-dressing powder medicine for antidiarrhea
08/30/2000CN1055858C Medicine for toothache
08/30/2000CN1055856C Medicine powder for stomatopathy and throat disease and its prepn. process
08/30/2000CN1055851C Medicine for treating gastropathy
08/30/2000CN1055848C Traditional Chinese patent drugs for curing gastrointestinal tract disease and gynopathy
08/30/2000CN1055838C Chinese herbal medicinal bag for infantile diarrhea and malnutrition
08/30/2000CN1055836C Fresh-juice Tianmami (gastrodia tuber sweet) health care food and making method thereof
08/29/2000US6111078 Staphylococcus aureus rsbU-1
08/29/2000US6111076 Human G-protein coupled receptor (HIBCD07)
08/29/2000US6110973 Methods for treating obesity and weight gain using optically pure (-)-bupropion
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity
08/29/2000US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents
08/29/2000US6110944 LTA4, hydrolase inhibitors
08/29/2000US6110940 Salts of an anti-migraine indole derivative
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/29/2000US6110919 Diazabicyclic neurokinin antagonists
08/29/2000US6110914 Spiroazabicyclic heterocyclic compounds
08/29/2000US6110896 Peptidyl compounds and their therapeutic use
08/29/2000US6110494 The mini-tablets which release cisapride or its salt in a controlled manner in the distal regions of gastrointestinal tract have a core of cisapride or a salt embedded in a hydrophilic polymer coated with a ph dependent polymer
08/29/2000US6110460 Methods of using morphogen analogs
08/29/2000CA2086754C Treatment of human lactation failure
08/24/2000WO2000049043A2 Human lipid-associated proteins
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000049011A1 Prothease inhibitors
08/24/2000WO2000048994A1 Thioamide derivatives
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048988A1 Phenylalaninol derivatives
08/24/2000WO2000048643A1 Biodegradable, injectable oligomer-polymer composition
08/24/2000WO2000048624A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000048610A1 Chemical compounds
08/24/2000WO2000048609A1 Chemical compounds
08/24/2000WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000WO2000048586A1 Remedies
08/24/2000WO2000048585A1 Effervescent laxatives
08/24/2000WO2000048447A2 Composition for treatment of external secretion disorders except hypolacrimation
08/24/2000WO2000024362A3 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000010611A3 Drug targeting
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000CA2363670A1 Chemical compounds
08/24/2000CA2362664A1 Utilization of orosomucoid in order to produce a pharmaceutical preparation
08/24/2000CA2362355A1 Effervescent laxatives
1 ... 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 ... 1258